These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 17656824)
1. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease. Fiala M; Cribbs DH; Rosenthal M; Bernard G J Alzheimers Dis; 2007 Jul; 11(4):457-63. PubMed ID: 17656824 [TBL] [Abstract][Full Text] [Related]
2. Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside. Fiala M CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):192-6. PubMed ID: 20205641 [TBL] [Abstract][Full Text] [Related]
3. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Halle A; Hornung V; Petzold GC; Stewart CR; Monks BG; Reinheckel T; Fitzgerald KA; Latz E; Moore KJ; Golenbock DT Nat Immunol; 2008 Aug; 9(8):857-65. PubMed ID: 18604209 [TBL] [Abstract][Full Text] [Related]
4. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. Fiala M; Lin J; Ringman J; Kermani-Arab V; Tsao G; Patel A; Lossinsky AS; Graves MC; Gustavson A; Sayre J; Sofroni E; Suarez T; Chiappelli F; Bernard G J Alzheimers Dis; 2005 Jun; 7(3):221-32; discussion 255-62. PubMed ID: 16006665 [TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers. Hjorth E; Zhu M; Toro VC; Vedin I; Palmblad J; Cederholm T; Freund-Levi Y; Faxen-Irving G; Wahlund LO; Basun H; Eriksdotter M; Schultzberg M J Alzheimers Dis; 2013; 35(4):697-713. PubMed ID: 23481688 [TBL] [Abstract][Full Text] [Related]
7. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease. Webers A; Heneka MT; Gleeson PA Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430 [TBL] [Abstract][Full Text] [Related]
8. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice. Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721 [TBL] [Abstract][Full Text] [Related]
9. A novel role for SHARPIN in amyloid-β phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer's disease. Krishnan D; Menon RN; Mathuranath PS; Gopala S Neurobiol Aging; 2020 Sep; 93():131-141. PubMed ID: 32165044 [TBL] [Abstract][Full Text] [Related]
10. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration. Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733 [TBL] [Abstract][Full Text] [Related]
11. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease. Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709 [TBL] [Abstract][Full Text] [Related]
12. The antimicrobial protection hypothesis of Alzheimer's disease. Moir RD; Lathe R; Tanzi RE Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800 [TBL] [Abstract][Full Text] [Related]
13. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers. Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448 [TBL] [Abstract][Full Text] [Related]
15. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Marsh SE; Abud EM; Lakatos A; Karimzadeh A; Yeung ST; Davtyan H; Fote GM; Lau L; Weinger JG; Lane TE; Inlay MA; Poon WW; Blurton-Jones M Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1316-25. PubMed ID: 26884167 [TBL] [Abstract][Full Text] [Related]
16. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Liu Y; Walter S; Stagi M; Cherny D; Letiembre M; Schulz-Schaeffer W; Heine H; Penke B; Neumann H; Fassbender K Brain; 2005 Aug; 128(Pt 8):1778-89. PubMed ID: 15857927 [TBL] [Abstract][Full Text] [Related]
17. TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation. Liu S; Liu Y; Hao W; Wolf L; Kiliaan AJ; Penke B; Rübe CE; Walter J; Heneka MT; Hartmann T; Menger MD; Fassbender K J Immunol; 2012 Feb; 188(3):1098-107. PubMed ID: 22198949 [TBL] [Abstract][Full Text] [Related]
18. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Salminen A; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T Prog Neurobiol; 2009 Feb; 87(3):181-94. PubMed ID: 19388207 [TBL] [Abstract][Full Text] [Related]
19. Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil. Park J; Baik SH; Mook-Jung I; Irimia D; Cho H Front Immunol; 2019; 10():2231. PubMed ID: 31611872 [TBL] [Abstract][Full Text] [Related]
20. Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protection. Cacace R; Zhou L; Hendrickx Van de Craen E; Buist A; Hoogmartens J; Sieben A; Cras P; Vandenberghe R; De Deyn PP; Oehlrich D; De Bondt A; Engelborghs S; Moechars D; Van Broeckhoven C Mol Psychiatry; 2023 Dec; 28(12):5380-5389. PubMed ID: 37433968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]